Tags : Atomica

B2B

LabGenius secures £11.59 million Series A Follow On investment led

LabGenius Closes $15M Series A Extension, led by Atomico, Brings Total Round to $25M Investment round, led by Atomico, with participation from current investors Lux Capital, Obvious Ventures, Kindred Capital and Inovia Capital, will boost R&D investment into the company’s discovery platform and therapeutic pipeline. LabGenius discovers next-generation protein therapeutics using robotic automation, synthetic biology […]Read More